Clinical Trials Browser

Phase 2 × Pancreatic Neoplasms × amatuximab × Clear all

NCT00570713 2015-09-09

An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer

Phase 2 Completed

155 enrolled 12 charts

Gastrointestinal

Pancreatic Neoplasms